moclobemide has been researched along with Behavior Disorders in 7 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the usefulness of moclobemide and amitriptyline in the treatment of fibromyalgia (FM) in females without psychiatric disorder." | 9.08 | A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. ( Hannonen, P; Isomeri, R; Malminiemi, K; Roponen, P; Yli-Kerttula, U, 1998) |
| "To study the usefulness of moclobemide and amitriptyline in the treatment of fibromyalgia (FM) in females without psychiatric disorder." | 5.08 | A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. ( Hannonen, P; Isomeri, R; Malminiemi, K; Roponen, P; Yli-Kerttula, U, 1998) |
| "Moclobemide is a reversible inhibitor of monoamine-oxidase-A (RIMA) and has been extensively evaluated in the treatment of a wide spectrum of depressive disorders and less extensively studied in anxiety disorders." | 4.82 | Moclobemide: therapeutic use and clinical studies. ( Bonnet, U, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnet, U | 1 |
| Baker, GB | 1 |
| Sowa, B | 1 |
| Todd, KG | 1 |
| Joffe, RT | 1 |
| Bakish, D | 1 |
| Hannonen, P | 1 |
| Malminiemi, K | 1 |
| Yli-Kerttula, U | 1 |
| Isomeri, R | 1 |
| Roponen, P | 1 |
| Priest, RG | 1 |
| Liebowitz, MR | 1 |
| Hollander, E | 1 |
| Schneier, F | 1 |
| Campeas, R | 1 |
| Welkowitz, L | 1 |
| Hatterer, J | 1 |
| Fallon, B | 1 |
3 reviews available for moclobemide and Behavior Disorders
| Article | Year |
|---|---|
Moclobemide: therapeutic use and clinical studies.
Topics: Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Drug Interactions | 2003 |
Moclobemide: a range of opportunities.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Humans; Mental Disorders; Moclobemide | 1992 |
Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.
Topics: Antidepressive Agents; Benzamides; Borderline Personality Disorder; Bulimia; Combined Modality Thera | 1990 |
2 trials available for moclobemide and Behavior Disorders
| Article | Year |
|---|---|
Combined SSRI-moclobemide treatment of psychiatric illness.
Topics: 1-Naphthylamine; Adult; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, | 1994 |
A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Benzamides; Di | 1998 |
2 other studies available for moclobemide and Behavior Disorders
| Article | Year |
|---|---|
Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
Topics: Amine Oxidase (Copper-Containing); Antidepressive Agents; Humans; Mental Disorders; Moclobemide; Mon | 2007 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; C | 1994 |